KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) EBT (2016 - 2025)

Historic EBT for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $122.8 million.

  • Insulet's EBT rose 4813.03% to $122.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.7 million, marking a year-over-year increase of 471.86%. This contributed to the annual value of $300.2 million for FY2024, which is 3988.82% up from last year.
  • Latest data reveals that Insulet reported EBT of $122.8 million as of Q3 2025, which was up 4813.03% from $28.4 million recorded in Q2 2025.
  • In the past 5 years, Insulet's EBT registered a high of $122.8 million during Q3 2025, and its lowest value of -$36.1 million during Q2 2022.
  • Moreover, its 5-year median value for EBT was $29.3 million (2022), whereas its average is $39.2 million.
  • Per our database at Business Quant, Insulet's EBT tumbled by 26321.84% in 2021 and then skyrocketed by 966666.67% in 2022.
  • Over the past 5 years, Insulet's EBT (Quarter) stood at $33.4 million in 2021, then crashed by 33.23% to $22.3 million in 2022, then soared by 383.41% to $107.8 million in 2023, then increased by 3.34% to $111.4 million in 2024, then increased by 10.23% to $122.8 million in 2025.
  • Its EBT stands at $122.8 million for Q3 2025, versus $28.4 million for Q2 2025 and $48.1 million for Q1 2025.